Clinical Omics – Products

Celemics co-founder and CEO Dr. Hyoki Kim announced a partnership with Strand Life Sciences to develop a bioinformatics solution capable of providing users with an accelerated means of producing high-quality,

Download this app note to discover a DIA workflow that can identify and quantify 5200 protein groups in single-shot analysis, delivers reproducible identification and quantification information and is suited for high-throughput proteomic profiling of hundreds of samples per day.

Company makes subsidized technology available as global bodies call for sequencing to confirm COVID-19 mutations.

Thermo Fisher Scientific has announced a new portfolio of hematology-oncology assays for the Ion Torrent Genexus System designed to enable a future in which turnaround times for next-generation sequencing results can be reduced to less than 24 hours.

The company has extended program benefits to oncology laboratories and fast-tracking access to comprehensive molecular profiling on the Genexus System.

Bruker has announced the release of the diaPASEF workflow, a novel data-independent acquisition (DIA) method, using overlapping windows in the ion mobility domain to trigger MS/MS

The collaboration with Thermo Fisher is in full alignment with Evosep’s vision to improve quality of life and patient care.

Thermo Fisher and Biognosys to develop industry-leading mass spectrometry-based workflows for the efficient analysis of proteins in complex biological matrices.

Thermo Fisher and NX Prenatal to develop clinical mass spectrometry-based workflows for monitoring
maternal and fetal health during pregnancy and evaluating risk of complications.

Thermo Fisher and NX Prenatal to develop clinical mass spectrometry-based workflows for monitoring
maternal and fetal health during pregnancy and evaluating risk of complications.